Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
392
-
Total 13F shares, excl. options
-
89.4M
-
Shares change
-
-310K
-
Total reported value, excl. options
-
$8.57B
-
Value change
-
-$28.1M
-
Put/Call ratio
-
2.42
-
Number of buys
-
184
-
Number of sells
-
-216
-
Price
-
$95.85
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q4 2020
492 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q4 2020.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 392 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.4M shares
of 99.6M outstanding shares and own 89.72% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (9.16M shares), FMR LLC (8.36M shares), VANGUARD GROUP INC (8.34M shares), BlackRock Inc. (7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.27M shares), Capital International Investors (3.41M shares), Bellevue Group AG (3.4M shares), STATE STREET CORP (2.48M shares), PERCEPTIVE ADVISORS LLC (1.9M shares), and RENAISSANCE TECHNOLOGIES LLC (1.81M shares).
This table shows the top 392 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.